These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure. Hokken-Koelega AC, Stijnen T, de Muinck Keizer-Schrama SM, Wit JM, Wolff ED, de Jong MC, Donckerwolcke RA, Abbad NC, Bot A, Blum WF. Lancet; 1991 Sep 07; 338(8767):585-90. PubMed ID: 1715501 [Abstract] [Full Text] [Related]
3. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency. Hokken-Koelega AC, Stijnen T, De Jong MC, Donckerwolcke RA, De Muinck Keizer-Schrama SM, Blum WF, Drop SL. J Clin Endocrinol Metab; 1994 Oct 07; 79(4):1185-90. PubMed ID: 7525628 [Abstract] [Full Text] [Related]
10. Long-term effects of growth hormone treatment on growth and puberty in patients with chronic renal insufficiency. Hokken-Koelega A, Mulder P, De Jong R, Lilien M, Donckerwolcke R, Groothof J. Pediatr Nephrol; 2000 Jul 07; 14(7):701-6. PubMed ID: 10912546 [Abstract] [Full Text] [Related]
11. Growth retardation in children with chronic renal insufficiency. Warady BA. J Am Soc Nephrol; 1998 Dec 07; 9(12 Suppl):S85-9. PubMed ID: 11443775 [Abstract] [Full Text] [Related]
12. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. Hokken-Koelega AC, Hackeng WH, Stijnen T, Wit JM, de Muinck Keizer-Schrama SM, Drop SL. J Clin Endocrinol Metab; 1990 Sep 07; 71(3):688-95. PubMed ID: 2394775 [Abstract] [Full Text] [Related]
13. Growth response to recombinant human growth hormone in short prepubertal children with chronic renal failure with or without dialysis. The European/Australian Study Group. Mehls O, Broyer M. Acta Paediatr Suppl; 1994 Apr 07; 399():81-7. PubMed ID: 7949624 [Abstract] [Full Text] [Related]
14. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G. Horm Res; 2005 Apr 07; 64(2):68-76. PubMed ID: 16113581 [Abstract] [Full Text] [Related]
15. Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment. Tönshoff B, Schaefer F, Mehls O. Pediatr Nephrol; 1990 Nov 07; 4(6):654-62. PubMed ID: 2088470 [Abstract] [Full Text] [Related]
18. Evaluation of clinical and laboratory parameters during 2 years of growth hormone treatment in prepubertal children with chronic renal failure. Simon D, Neol M, Brun P, Porquet D, Rocchicioli P, Loirat C, Czernichow P. Eur J Pediatr; 1996 Aug 07; 155(8):688-94. PubMed ID: 8839726 [Abstract] [Full Text] [Related]
20. Growth in children with renal failure. Lewy JE, New MI. Am J Med; 1975 Jan 07; 58(1):65-8. PubMed ID: 1090152 [Abstract] [Full Text] [Related] Page: [Next] [New Search]